171 related articles for article (PubMed ID: 36822010)
1. Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A
Int J Drug Policy; 2023 Mar; 113():103976. PubMed ID: 36822010
[TBL] [Abstract][Full Text] [Related]
2. Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
Price O; Man N; Bruno R; Dietze P; Salom C; Lenton S; Grigg J; Gibbs D; Wilson T; Degenhardt L; Chan R; Thomas N; Peacock A
Addiction; 2022 Jan; 117(1):182-194. PubMed ID: 34159666
[TBL] [Abstract][Full Text] [Related]
3. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
4. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.
Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P
Addiction; 2015 Jan; 110(1):120-8. PubMed ID: 25220170
[TBL] [Abstract][Full Text] [Related]
5. Trends in methamphetamine use, markets and harms in Australia, 2003-2019.
Man N; Sisson SA; McKetin R; Chrzanowska A; Bruno R; Dietze PM; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A
Drug Alcohol Rev; 2022 Jul; 41(5):1041-1052. PubMed ID: 35604870
[TBL] [Abstract][Full Text] [Related]
6. Changes in and correlates of Australian public attitudes toward illicit drug use.
Weatherburn D; Alexeev S; Livingston M
Drug Alcohol Rev; 2022 Jul; 41(5):1029-1040. PubMed ID: 34963035
[TBL] [Abstract][Full Text] [Related]
7. The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
Chalmers J; Matthew-Simmons F; Hughes CE
Curr Drug Abuse Rev; 2013 Jun; 6(2):98-111. PubMed ID: 24308523
[TBL] [Abstract][Full Text] [Related]
8. Concerts, bars, parties, and raves: Differential risk for drug use among high school seniors according to venue attendance.
Palamar JJ; Rutherford C; Cleland CM; Keyes KM
Subst Abus; 2022; 43(1):785-791. PubMed ID: 35113010
[No Abstract] [Full Text] [Related]
9. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
[TBL] [Abstract][Full Text] [Related]
10. The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.
Rathnayake K; Agius PA; Ward B; Hickman M; Maher L; Stoové M; Doyle JS; Hellard M; Wilkinson A; Quinn B; Crawford S; Sutton K; Dietze P
Addiction; 2023 Aug; 118(8):1557-1568. PubMed ID: 36918365
[TBL] [Abstract][Full Text] [Related]
11. Drug affordability-potential tool for comparing illicit drug markets.
Groshkova T; Cunningham A; Royuela L; Singleton N; Saggers T; Sedefov R
Int J Drug Policy; 2018 Jun; 56():187-196. PubMed ID: 29459212
[TBL] [Abstract][Full Text] [Related]
12. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
[TBL] [Abstract][Full Text] [Related]
13. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
15. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
[TBL] [Abstract][Full Text] [Related]
16. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
Matthews AJ; Bruno R; Dietze P; Butler K; Burns L
Drug Alcohol Depend; 2014 Nov; 144():218-24. PubMed ID: 25282306
[TBL] [Abstract][Full Text] [Related]
17. How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia.
Horyniak D; Stoové M; Degenhardt L; Aitken C; Kerr T; Dietze P
Int J Drug Policy; 2015 Jan; 26(1):43-50. PubMed ID: 25304048
[TBL] [Abstract][Full Text] [Related]
18. Illicit drug consumption estimated using wastewater analysis and compared by settlement size in New Zealand.
Chappell A; Armstrong B; Jay E; Phung K; McCormick S; Grigg S; Waite B
Sci Total Environ; 2022 Oct; 843():156956. PubMed ID: 35760179
[TBL] [Abstract][Full Text] [Related]
19. Shifts in drug seizures in the United States during the COVID-19 pandemic.
Palamar JJ; Le A; Carr TH; Cottler LB
Drug Alcohol Depend; 2021 Apr; 221():108580. PubMed ID: 33674175
[TBL] [Abstract][Full Text] [Related]
20. Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009-2015) in South East Queensland, Australia.
Lai FY; O'Brien JW; Thai PK; Hall W; Chan G; Bruno R; Ort C; Prichard J; Carter S; Anuj S; Kirkbride KP; Gartner C; Humphries M; Mueller JF
Sci Total Environ; 2016 Oct; 568():803-809. PubMed ID: 27325011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
